Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy
- 28 December 2012
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 28 (s2) , 40-46
Abstract
Summary: Diabetes mellitus is a metabolic disorder resulting from a defect in insulin secretion, insulin action or both. An effect of this process is chronic hyperglycaemia with disorder of carbohydrate, fat and protein metabolism and with long‐term complications of diabetes including retinopathy, nephropathy and neuropathy. Latent autoimmune diabetes in adults (LADA) is a type of autoimmune diabetes that resembles Type 1 diabetes (T1D), however, it shows a later onset and slower progression towards insulin necessity. Epidemiological studies suggest that LADA may account for 2–12% of all cases of diabetes in adult population. The epidemiology and phenotypic characteristics of LADA may vary between Caucasian and Asian diabetic patients as lifestyle, food habits and body mass index differ between these two populations. Data on LADA from population‐based studies in Asia are sparse and only few studies have looked at it.A number of attractive therapeutic interventions may be envisaged for prevention of beta‐cell loss in LADA, including hypoglycaemic and immunomodulatory agents. Because the autoimmune process in LADA seems to be slower than in childhood T1D, there is a wider window of opportunities for intervention. In deciding the best therapeutic approach, features of LADA should guide therapy including presence of other comorbidities that may influence the therapeutic choice.Keywords
This publication has 63 references indexed in Scilit:
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trialThe Lancet, 2011
- Prevalence and Correlates of Latent Autoimmune Diabetes in Adults in Tianjin, ChinaDiabetes Care, 2010
- Latent autoimmune diabetes in adults: A distinct but heterogeneous clinical entityWorld Journal of Diabetes, 2010
- β-Cell Protection and Therapy for Latent Autoimmune Diabetes in AdultsDiabetes Care, 2009
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 DiabetesNew England Journal of Medicine, 2008
- Exendin-4 Stimulation of Cyclin A2 in β-Cell ProliferationDiabetes, 2008
- GAD65 Autoantibody Responses in Japanese Latent Autoimmune Diabetes in Adult PatientsDiabetes Care, 2008
- Pioglitazone and sulfonylureas: effectively treating type 2 diabetesInternational Journal Of Clinical Practice, 2007
- NOD Mouse Diabetes: The Ubiquitous Mouse Hsp60 is a β-Cell Target Antigen of Autoimmune T CellsJournal of Autoimmunity, 1996
- Prevention of adoptive transfer in BB rats by prophylactic insulin treatmentDiabetes, 1992